Literature DB >> 11395588

Transthoracic monitoring of the impedance of the right lung in patients with cardiogenic pulmonary edema.

G Charach1, P Rabinovich, I Grosskopf, M Weintraub.   

Abstract

OBJECTIVE: To evaluate the suitability of the new electrical impedance monitor RS-205 for monitoring of cardiogenic pulmonary edema (CPE).
DESIGN: Prospective, controlled study.
SETTING: A department of internal medicine in a 1,200-bed university-affiliated, teaching hospital. PATIENTS: Sixty patients, aged 52-80 yrs, 30 without CPE (controls) and 30 with or at high risk for CPE.
INTERVENTIONS: Internal thoracic impedance (ITI) was monitored by the RS-205. The RS-205 is approximately three times more sensitive than the Kubicek monitor, and it eliminates the effect of the drift of skin-to-electrode impedance. This is achieved by eliminating skin electrode impedance by a special algorithm, thus allowing measurement of ITI rather than total transthoracic impedance. Measuring ITI, the main component of which is lung impedance, is a noninvasive and safe method. CPE was diagnosed in accordance with well-accepted clinical and roentgenological criteria.
MEASUREMENTS AND MAIN RESULTS: The controls' initial ITI was 68.3 +/- 12.38 ohms. During 6 hrs of monitoring, the ITI attained a minimum average value of -1.3 +/- 2.08% and a maximum average value of 4.6 +/- 3.56% relative to baseline. In all patients entering CPE, ITI decreased by 14.4 +/- 5.42% on the average (p <.001) 1 hr before the appearance of clinical symptoms. In patients with evolving CPE, ITI decreased significantly compared with controls (22.25 +/- 9.82%, p <.001). In patients at the peak of pulmonary edema, ITI was 2.1 times lower than in the control group (33.1 +/- 10.90 ohms, p <.001). In the last hour before the resolution of CPE, ITI increased in all patients by 17.7 +/- 19.74% compared with the peak of disease (p <.05). After the resolution of pulmonary edema, ITI increased in all patients by 44.14 +/- 26.90% compared with the peak of disease (p <.001). Importantly, the trend in ITI in all patients changed in accordance with the dynamics of CPE. A mixed general linear model shows that ITI values correlated well with the degree of crepitation, a direct characteristics of CPE.
CONCLUSIONS: The RS-205 is suitable for monitoring patients at high risk of CPE development. It enables detection of CPE and the monitoring of patients at all stages of CPE.

Entities:  

Mesh:

Year:  2001        PMID: 11395588     DOI: 10.1097/00003246-200106000-00008

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  5 in total

1.  Prediction of cardiogenic pulmonary edema onset by monitoring right lung impedance.

Authors:  Michael Shochat; Gideon Charach; Shmuel Meyler; Simcha Meisel; Moshe Weintraub; Galina Mengeritsky; Morris Mosseri; Pavel Rabinovich
Journal:  Intensive Care Med       Date:  2006-06-15       Impact factor: 17.440

Review 2.  Measuring impedance in congestive heart failure: current options and clinical applications.

Authors:  W H Wilson Tang; Wilson Tong
Journal:  Am Heart J       Date:  2008-12-16       Impact factor: 4.749

3.  Ambulatory respiratory rate trends identify patients at higher risk of worsening heart failure in implantable cardioverter defibrillator and biventricular device recipients: a novel ambulatory parameter to optimize heart failure management.

Authors:  Stephan Goetze; Yi Zhang; Qi An; Viktoria Averina; Pier Lambiase; Richard Schilling; Hans-Joachim Trappe; Siegmund Winter; Nicholas Wold; Ljubomir Manola; Dries Kestens
Journal:  J Interv Card Electrophysiol       Date:  2015-04-12       Impact factor: 1.900

4.  Preventive treatment of alveolar pulmonary edema of cardiogenic origin.

Authors:  Gideon Charach; Michael Shochat; Alexander Rabinovich; Oded Ayzenberg; Jacob George; Lior Charach; Pavel Rabinovich
Journal:  J Geriatr Cardiol       Date:  2012-12       Impact factor: 3.327

5.  Internal thoracic impedance - a useful method for expedient detection and convenient monitoring of pleural effusion.

Authors:  Gideon Charach; Olga Rubalsky; Lior Charach; Alexander Rabinovich; Ori Argov; Ori Rogowski; Jacob George
Journal:  PLoS One       Date:  2015-04-28       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.